News & Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
Filters
Filters
Therapeutic Areas
In Vivo AI Platforms
Mental Illness
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain
Sleep & Seizure Disorders
Rare CNS Disorders
Traumatic Brain Injury
Specific Disorders
Apply Filters
Filters
PUBLICATION
Standardized Behavioral Test Battery to Identify and Validate Targets for Neuropsychiatric Diseases and Pain.
April 10, 2008
PUBLICATION
Genetic disruption of both tryptophan hydroxylase genes strongly reduces serotonin in the brain and affects behavior in models sensitive to antidepressants
March 31, 2008
PUBLICATION
Netrin-G2 and netrin-G2 ligand are both required for normal auditory responsiveness.
March 18, 2008
PUBLICATION
Use of a platform in an automated open-field to enhance assessment of anxiety-like behaviors in mice.
December 5, 2007
PUBLICATION
New methodological aspects of microdialysis.
November 25, 2007
PUBLICATION
Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation.
October 20, 2007
PUBLICATION
Measurement of brain microglial proliferation rates in vivo in response to neuroinflammatory stimuli: application to drug discovery.
October 7, 2007
PUBLICATION
Measurement of cell proliferation by heavy water labeling.
September 8, 2007
PUBLICATION
Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.
August 14, 2007